The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.
While some apps like Character.ai and Replika allow people to transform their chatbots into customised human characters, it’s become important for those specialising in mental health to ensure their ...